SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Comerica Incorporated (CMA) trades at a trailing P/E of 16.8, forward P/E of 16.5. Trailing earnings yield is 5.97%, forward earnings yield 6.06%. PEG 3.10.
Criteria proven by this page:
- VALUE (43/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 16.5 (down from trailing 16.8) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 3.10 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 5.97% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 6.06% as earnings recover.
- Analyst consensus target $69.50 (-21.6% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 51/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
43/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CMA
Valuation Multiples
P/E (TTM)16.8
Forward P/E16.5
PEG Ratio3.10
Forward PEG11.01
P/B Ratio0.00
P/S Ratio2.46
EV/EBITDA0.0
Per Share Data
EPS (TTM)$5.29
Forward EPS (Est.)$5.37
Book Value / Share$0.00
Revenue / Share$36.08
FCF / Share$0.00
Yields & Fair Value
Earnings Yield5.97%
Forward Earnings Yield6.06%
Dividend Yield0.00%
Analyst Target$69.50 (-21.6%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.69 |
$2.96B |
$477M |
16.1% |
| 2017 |
$4.17 |
$3.29B |
$743M |
22.6% |
| 2018 |
$7.22 |
$3.6B |
$1.24B |
34.4% |
| 2019 |
$7.89 |
$3.81B |
$1.2B |
31.5% |
| 2020 |
$3.44 |
$3.09B |
$497M |
16.1% |
| 2021 |
$8.32 |
$3.02B |
$1.17B |
38.6% |
| 2022 |
$8.44 |
$3.74B |
$1.15B |
30.8% |
| 2023 |
$6.42 |
$5.25B |
$881M |
16.8% |
| 2024 |
$5.02 |
$4.99B |
$698M |
14% |
| 2025 |
$5.29 |
$4.8B |
$723M |
15.1% |
